History
Biosergen is Developing BSG005 against Invasive Fungal Infections
| Based on two decades of scientific work at Norwegian University of Science and Technology (NTNU) in Trondheim in collaboration with the Department of Biotechnology and Nanomedicine at SINTEF, originally funded by the Research Council of Norway |
| Using state-of-art gene editing techniques to develop an improved version of Nystatin, a naturally occurring fungicidal chemical in the bacterial strain Streptomyces noursei |
| The researchers modified several gene clusters in an attempt to retain or even improve the efficacy of Amphotericin B while removing well-known dose limiting toxicity |
| They eventually expressed and evaluated in various in vitro and in vivo models more than 20 drug candidates |
